BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33006810)

  • 1. Associations between Helicobacter pylori with nonalcoholic fatty liver disease and other metabolic conditions in Guatemala.
    Alvarez CS; Florio AA; Butt J; Rivera-Andrade A; Kroker-Lobos MF; Waterboer T; Camargo MC; Freedman ND; Graubard BI; Lazo M; Guallar E; Groopman JD; Ramírez-Zea M; McGlynn KA
    Helicobacter; 2020 Dec; 25(6):e12756. PubMed ID: 33006810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori infection is not associated with nonalcoholic fatty liver disease.
    Baeg MK; Yoon SK; Ko SH; Noh YS; Lee IS; Choi MG
    World J Gastroenterol; 2016 Feb; 22(8):2592-600. PubMed ID: 26937147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter hepaticus and Helicobacter bilis in liver and biliary cancers from ATBC and PLCO.
    Murphy G; Freedman ND; Abnet CC; Albanes D; Cross AJ; Huang WY; Koshiol J; McGlynn K; Parisi D; Männistö S; Weinstein SJ; Waterboer T; Butt J
    Helicobacter; 2024; 29(1):e13053. PubMed ID: 38332674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between cagA negative Helicobacter pylori status and nonalcoholic fatty liver disease among adults in the United States.
    Kang SJ; Kim HJ; Kim D; Ahmed A
    PLoS One; 2018; 13(8):e0202325. PubMed ID: 30110395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori infection is not associated with fatty liver disease including non-alcoholic fatty liver disease: a large-scale cross-sectional study in Japan.
    Okushin K; Takahashi Y; Yamamichi N; Shimamoto T; Enooku K; Fujinaga H; Tsutsumi T; Shintani Y; Sakaguchi Y; Ono S; Kodashima S; Fujishiro M; Moriya K; Yotsuyanagi H; Mitsushima T; Koike K
    BMC Gastroenterol; 2015 Feb; 15():25. PubMed ID: 25880912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease.
    Kim TJ; Sinn DH; Min YW; Son HJ; Kim JJ; Chang Y; Baek SY; Ahn SH; Lee H; Ryu S
    J Gastroenterol; 2017 Nov; 52(11):1201-1210. PubMed ID: 28382402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of
    Xu G; Ma S; Dong L; Mendez-Sanchez N; Li H; Qi X
    Can J Gastroenterol Hepatol; 2023; 2023():5521239. PubMed ID: 36742347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between Helicobacter pylori infection and risk of nonalcoholic fatty liver disease: An updated meta-analysis.
    Mantovani A; Turino T; Altomari A; Lonardo A; Zoppini G; Valenti L; Tilg H; Byrne CD; Targher G
    Metabolism; 2019 Jul; 96():56-65. PubMed ID: 31047909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H. pylori is related to NAFLD but only in female: A Cross-sectional Study.
    Wang J; Dong F; Su H; Zhu L; Shao S; Wu J; Liu H
    Int J Med Sci; 2021; 18(11):2303-2311. PubMed ID: 33967606
    [No Abstract]   [Full Text] [Related]  

  • 10. The associations among Helicobacter pylori infection, white blood cell count and nonalcoholic fatty liver disease in a large Chinese population.
    Yu YY; Cai JT; Song ZY; Tong YL; Wang JH
    Medicine (Baltimore); 2018 Nov; 97(46):e13271. PubMed ID: 30431613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori infection may increase the severity of nonalcoholic fatty liver disease via promoting liver function damage, glycometabolism, lipid metabolism, inflammatory reaction and metabolic syndrome.
    Chen C; Zhang C; Wang X; Zhang F; Zhang Z; Ma P; Feng S
    Eur J Gastroenterol Hepatol; 2020 Jul; 32(7):857-866. PubMed ID: 31714387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Helicobacter pylori infection associated with non-alcoholic fatty liver disease in individuals undergoing bariatric surgery? Cross-sectional study.
    Valadares EC; Gestic MA; Utrini MP; Chaim FDM; Chaim EA; Cazzo E
    Sao Paulo Med J; 2023; 141(5):e2022517. PubMed ID: 37042863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance between Helicobacter
    Mohammadifard M; Saremi Z; Rastgoo M; Akbari E
    J Med Life; 2019; 12(2):168-172. PubMed ID: 31406519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between nonalcoholic fatty liver disease and
    Yan P; Yu B; Li M; Zhao W
    Saudi Med J; 2021 Jul; 42(7):735-741. PubMed ID: 34187917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori infection increases the risk of nonalcoholic fatty liver disease: Possible relationship from an updated meta-analysis.
    Liu C; Wu Q; Ren R; Zhang Z; Shi Y; Li H
    Medicine (Baltimore); 2023 Aug; 102(33):e34605. PubMed ID: 37603516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between Helicobacter pylori infection and nonalcoholic fatty liver disease: a systemic review and meta-analysis.
    Ning L; Liu R; Lou X; Du H; Chen W; Zhang F; Li S; Chen X; Xu G
    Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):735-742. PubMed ID: 30950907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between Helicobacter pylori infection and nonalcoholic fatty liver disease: What should we expect from a meta-analysis?
    Wei L; Ding HG
    Medicine (Baltimore); 2021 Aug; 100(31):e26706. PubMed ID: 34397807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori and non-alcoholic fatty liver disease: A new enigma?
    Abdel-Razik A; Mousa N; Shabana W; Refaey M; Elhelaly R; Elzehery R; Abdelsalam M; Elgamal A; Nassar MR; Abu El-Soud A; Seif AS; Tawfik AM; El-Wakeel N; Eldars W
    Helicobacter; 2018 Dec; 23(6):e12537. PubMed ID: 30246507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence estimates of Helicobacter species infection in pancreatic and biliary tract cancers.
    Osaki T; Lin Y; Sasahira N; Ueno M; Yonezawa H; Hojo F; Okuda M; Matsuyama M; Sasaki T; Kobayashi S; Tezuka S; Tanaka K; Dan N; Kuruma S; Egawa N; Kamiya S; Kikuchi S
    Helicobacter; 2022 Feb; 27(1):e12866. PubMed ID: 35005807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of non-alcoholic fatty liver disease and metabolic risk factors in Guatemala: A population-based study.
    Rivera-Andrade A; Kroker-Lobos MF; Lazo M; Freedman ND; Smith JW; Torres O; McGlynn KA; Groopman JD; Guallar E; Ramirez-Zea M
    Nutr Metab Cardiovasc Dis; 2019 Feb; 29(2):191-200. PubMed ID: 30573307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.